Mouray Elisabeth, Moutiez Mireille, Girault Sophie, Sergheraert Christian, Florent Isabelle, Grellier Philippe
USM 0504 Biologie Fonctionnelle des Protozoaires, EA3335, Département Régulations, Développement, Diversité Moléculaire, CP 52, Muséum National d'Histoire Naturelle, 75231 Paris cedex 05, France.
Biochimie. 2007 Mar;89(3):337-46. doi: 10.1016/j.biochi.2006.11.001. Epub 2006 Nov 27.
We have previously reported the isolation of a 52,000 M(r) protein (Pf52) displaying consensus sequences for thiol:disulfide oxidoreductases. Pf52 therefore represents the plasmodial protein disulfide isomerase (PDI). It has been renamed PfPDI and correlates to MAL8P1.17 in the annotated genome of P. falciparum (3D7 strain). Antibodies were raised against recombinant (His)(6)-tagged forms of PfPDI devoid of its signal peptide sequence, demonstrating a major co-localization of PfPDI with endoplasmic reticulum-resident proteins, PfBIP and PfERC, but not with the Golgi marker PfERD2. Recombinant PfPDI displayed typical biochemical functions of PDIs: oxidase/isomerase and reductase activities, as well as a chaperone-like behavior on the denaturated protein rhodanese. These activities were comparable to those measured for the purified native bovine PDI and the human recombinant PDI. The antiplasmodial compound DS61 does inhibit the recombinant PfPDI oxidase/isomerase activity but not that of the human recombinant PDI, suggesting structural differences between both enzymes. However, a discrepancy between the inhibitory activity of DS61 on the recombinant PfPDI (IC(50) of 430 microM) and its in vitro antiplasmodial activity (IC(50) of 0.1 microM) was observed, suggesting that PfPDI is not the only target of DS61. Taking into account its biochemical properties and its intracellular localization, the involvement of PfPDI in the parasite protein folding is discussed, as well as its potential for the development of alternative antimalarial chemotherapy strategies.
我们之前报道过分离出一种52,000 M(r)的蛋白质(Pf52),其具有硫醇:二硫键氧化还原酶的共有序列。因此,Pf52代表疟原虫蛋白二硫键异构酶(PDI)。它已被重新命名为PfPDI,与恶性疟原虫(3D7株)注释基因组中的MAL8P1.17相关。制备了针对去除信号肽序列的重组(His)6标记形式的PfPDI的抗体,结果表明PfPDI主要与内质网驻留蛋白PfBIP和PfERC共定位,但不与高尔基体标记物PfERD2共定位。重组PfPDI表现出PDI的典型生化功能:氧化酶/异构酶和还原酶活性,以及对变性蛋白硫氰酸酶的伴侣样行为。这些活性与纯化的天然牛PDI和人重组PDI所测得的活性相当。抗疟化合物DS61确实抑制重组PfPDI的氧化酶/异构酶活性,但不抑制人重组PDI的活性,这表明两种酶之间存在结构差异。然而,观察到DS61对重组PfPDI的抑制活性(IC50为430 microM)与其体外抗疟活性(IC50为0.1 microM)之间存在差异,这表明PfPDI不是DS61的唯一靶点。考虑到其生化特性和细胞内定位,讨论了PfPDI在寄生虫蛋白质折叠中的作用,以及其在开发替代抗疟化疗策略方面的潜力。